Pathophysiology of transfusional iron overload: contrasting patterns in thalassemia major and sickle cell disease.
about
MRI Measurements of Iron Load in Transfusion-Dependent Patients: Implementation, Challenges, and PitfallsmRNA regulation of cardiac iron transporters and ferritin subunits in a mouse model of iron overloadIron-chelating and anti-lipid peroxidation properties of 1-(N-acetyl-6-aminohexyl)-3-hydroxy-2-methylpyridin-4-one (CM1) in long-term iron loading β-thalassemic mice.Long-term safety and efficacy of deferasirox (Exjade) for up to 5 years in transfusional iron-overloaded patients with sickle cell disease.α-Globin as a molecular target in the treatment of β-thalassemiaThe Regulation of Iron Absorption and Homeostasis.Extramedullary haematopoiesis correlates with genotype and absence of cardiac iron overload in polytransfused adults with thalassaemiaSex differences and steroid modulation of cardiac iron in a mouse model of iron overload.Iron overload correlates with serum liver fibrotic markers and liver dysfunction: Potential new methods to predict iron overload-related liver fibrosis in thalassemia patientsChelation treatment in sickle-cell-anaemia: much ado about nothing?Chronically transfused pediatric sickle cell patients are protected from cardiac iron overload.Sickle-cell disease and the heart: review of the current literature.Iron metabolism: interactions with normal and disordered erythropoiesisCurrent approach to iron chelation in children.Labile iron in cells and body fluids: physiology, pathology, and pharmacology.The exochelins of pathogenic mycobacteria: unique, highly potent, lipid- and water-soluble hexadentate iron chelators with multiple potential therapeutic uses.Utility of labile plasma iron and transferrin saturation in addition to serum ferritin as iron overload markers in different underlying anemias before and after deferasirox treatment.Arterio-venous fistula for automated red blood cells exchange in patients with sickle cell disease: Complications and outcomes.A reappraisal of the mechanisms underlying the cardiac complications of sickle cell anemia.Impact of prohepcidin levels and iron parameters on early post-transplantation toxicities.To 'umbrella' the gonads in transfusion rainDifferences in circulating non-transferrin-bound iron after oral administration of ferrous sulfate, sodium iron EDTA, or iron polymaltose in women with marginal iron stores.Gene Addition Strategies for β-Thalassemia and Sickle Cell Anemia.Multiple red blood cell transfusions and iron overload in very low birthweight infants.RETRACTED: Identification of a novel Na+-coupled Fe3+-citrate transport system, distinct from mammalian INDY, for uptake of citrate in mammalian cells.Evaluation of hepatic iron overload in Chinese children with β-thalassemia major.Extramedullary hematopoiesis is associated with lower cardiac iron loading in chronically transfused thalassemia patients.Severe cardiac iron toxicity in two adults with sickle cell disease.
P2860
Q28072173-BC85E46C-38A7-445B-9D4A-E99C79613B2DQ28384189-867D1C82-2495-499B-AFC7-74ED516E153DQ33682055-0D67EA92-AF6B-428C-8430-4B7D7E72C398Q35206809-2CF578C7-D2BC-4D32-9C41-DE566F73DE9AQ35836891-E19D711E-225E-476A-ABBA-D3BE517AA0CEQ37543492-BFED1A4D-6C34-45B1-B2EF-F738CC2D3996Q37602349-FC6487FF-6D85-4618-BCEE-984B276F00DBQ37624725-EBE6A100-CF2B-4BB5-8BE1-AC2F8875E6A7Q37741820-89C8942B-2350-45B3-BDA6-127D576C5E40Q37894822-5553E9F6-3CDE-4575-A02B-270176DA7CFAQ37981248-942313AD-65ED-4C0F-93F9-80CA42FFEC35Q38005233-5DDB864C-02CB-4542-BCDD-14B391B0F51AQ38007163-3AB59311-A4AD-4AAC-B887-A25481139E36Q38197269-39A473B1-C736-4C96-9BC4-3CC6FF380BB4Q38198634-0DF03158-C1F4-4861-A011-8A6F3E13AD7CQ38200693-362E9830-C41C-48AD-B7E5-A7E135E4A370Q38416115-BE0E810A-FAF1-410A-8703-4E343710A4F3Q39215776-CE63298F-8C8C-45DB-8EDE-7E7D33D85E2FQ39269713-57654C6E-78B8-48F7-AC12-1EB20589648EQ40312709-EFA82930-D28E-4046-BE60-B49554D55574Q41933147-CA64068D-3897-4F97-B8EB-E486DB09F2A8Q43883502-055098B1-4AFB-4FFC-B7F1-E1A850F25D06Q45874313-2D15D25F-9B84-4171-AD27-E02AA8BFCCAAQ47866026-5D24ED3A-EDEE-49E3-A04C-2D3252C08746Q48509517-47BF9D25-4841-4002-B4BA-4D8896094F02Q50525194-06F0ED42-6C8B-4C43-AF98-B7C4FB7D5846Q50853631-10650F0F-B010-4585-971B-D283E5C49577Q51235758-B6B248D2-69F7-41BE-A9D8-33AF41020418
P2860
Pathophysiology of transfusional iron overload: contrasting patterns in thalassemia major and sickle cell disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Pathophysiology of transfusion ...... major and sickle cell disease.
@en
Pathophysiology of transfusion ...... major and sickle cell disease.
@nl
type
label
Pathophysiology of transfusion ...... major and sickle cell disease.
@en
Pathophysiology of transfusion ...... major and sickle cell disease.
@nl
prefLabel
Pathophysiology of transfusion ...... major and sickle cell disease.
@en
Pathophysiology of transfusion ...... major and sickle cell disease.
@nl
P2860
P1433
P1476
Pathophysiology of transfusion ...... major and sickle cell disease
@en
P2093
John B Porter
P2860
P304
P356
10.3109/03630260903346627
P478
33 Suppl 1
P577
2009-01-01T00:00:00Z